iOS app Android app


New Sleep Medications: Thinking About Profits, Not Dreams

Kelly Bulkeley, Ph.D. | Posted 03.17.2014 | Science
Kelly Bulkeley, Ph.D.

The Dec. 9, 2013, issue of The New Yorker published a detailed but rather misguided article by Ian Parker, "The Big Sleep," about the complicated tangle of profit, science, and psychology in the search for better drugs to aid sleep.

FDA Rejects New Insomnia Drug, Seeks Lower Dose

Reuters | Posted 08.31.2013 | Healthy Living

July 1 (Reuters) - U.S. health regulators have rejected Merck & Co's new insomnia drug application but opened the door to approving a lower-dose ver...

New Kind Of Sleeping Pill Moves Step Closer To Approval By FDA

Reuters | Posted 07.23.2013 | Healthy Living

By Toni Clarke WASHINGTON, May 22 (Reuters) - Merck & Co's experimental insomnia drug moved a step closer to U.S. approval on Wednes...

FDA Questions Proposed Dosing Levels For New Sleep Drug

Reuters | Posted 07.20.2013 | Healthy Living

* Reviewers say lower doses of suvorexant safer than high * Cite risk of next-day sedation, suicidal thinking * Merck shares fall 1 percent ...

New Sleeping Pill Doesn't Cause Memory Side Effects, Animal Studies Suggest

Reuters | Posted 06.03.2013 | Healthy Living

* Findings suggest drug may not impair memory, attention * Merck's sleep drug now before FDA By Julie Steenhuysen ...

New Kind Of Sleeping Pill Works By Blocking Wakefulness

The Huffington Post | Amanda L. Chan | Posted 06.26.2012 | Healthy Living

A new kind of sleeping pill, called suvorexant, was shown to be effective at helping people fall -- and stay -- asleep in clinical trials, according t...